Inhibitory effect of combined transfection of antisense oligonucleotides of VEGF-C and COX-2 on the expression of VEGF-C in breast carcinoma cell line
Huang Yuan
Abstract
Huang Yuan
Abstract
Objective:To investigate the effect of combined transfection of antisense oligonucleotides (ASODNs) of vascular endothelial growth factor-C (VEGF-C) and cyclooxygenase-2 (COX-2) by cationic liposome (LIP) on the expression of VEGF-C in breast carcinoma MDA-MB-231 cells. Methods:Cytotoxicity of ASODNs on MDA-MB-231 cells was measured by MTT assay and the optimal concentration for transfection was determined. The transcription of VEGF-C in breast carcinoma cells was detected by RT-PCR. The protein expression of VEGF-C was detected by immunohistochemical staining and confocal laser scanning microscopy in MDA-MB-231 cells after co-transfection of VEGF-C and COX-2 ASODN. Results:No cytotoxic effect was found when ASODNs/LIP was transfected at 0.2 mmol/L+2.5 mL/L. The inhibitory ratio on VEGF-C mRNA transcription was 70.37% in the combined transfection group, which was significantly higher than VEGF-C transfection group and COX-2 transfection group (48.15% and 42.21%, P0.01). The protein expression of VEGF-C was significantly lower in the combined transfection group than that in only VEGF-C or COX-2 transfection group (P0.01). Conclusion: Combined transfection of VEGF-C and COX-2 ASODN markedly decreases the expressions of VEGF-C at mRNA and protein levels in MDA-MB-231 cells. COX-2 maybe involved in the induction of VEGF-C expression in breast cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effect of combined transfection of antisense oligonucleotides (ASODNs) of vascular endothelial growth factor-C (VEGF-C) and cyclooxygenase-2 (COX-2) by cationic liposome (LIP) on the expression of VEGF-C in breast carcinoma MDA-MB-231 cells. Methods:Cytotoxicity of ASODNs on MDA-MB-231 cells was measured by MTT assay and the optimal concentration for transfection was determined. The transcription of VEGF-C in breast carcinoma cells was detected by RT-PCR. The protein expression of VEGF-C was detected by immunohistochemical staining and confocal laser scanning microscopy in MDA-MB-231 cells after co-transfection of VEGF-C and COX-2 ASODN. Results:No cytotoxic effect was found when ASODNs/LIP was transfected at 0.2 mmol/L+2.5 mL/L. The inhibitory ratio on VEGF-C mRNA transcription was 70.37% in the combined transfection group, which was significantly higher than VEGF-C transfection group and COX-2 transfection group (48.15% and 42.21%, P0.01). The protein expression of VEGF-C was significantly lower in the combined transfection group than that in only VEGF-C or COX-2 transfection group (P0.01). Conclusion: Combined transfection of VEGF-C and COX-2 ASODN markedly decreases the expressions of VEGF-C at mRNA and protein levels in MDA-MB-231 cells. COX-2 maybe involved in the induction of VEGF-C expression in breast cancer.
Key concepts: Transfection, Molecular biology, Vascular endothelial growth factor, Biology, Cell culture, Messenger RNA, Cancer research, VEGF receptors